During kinetic and equilibrium investigations of cold agglutinins it became apparent that ordinary techniques for “instantaneous sampling”, that is, rapid centrifugation of samples ...

Sanofi has won FDA approval for its sutimlimab for cold agglutinin disease (CAD) at the second time of asking, becoming the first approved therapy for the rare blood disorder in the US.